Stockreport

Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunit...

Visionary Holdings Inc. - Common Shares  (GV) 
NASDAQ:AMEX Investor Relations: ir.goldfieldcorp.com
PDF TORONTO, Oct. 22, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise li [Read more]